Syqe Medical Announces Agreement with Israeli Ministry of Defense to Provide SyqeAir Technology to Veterans, Business News

TEL AVIV, Israel, 15 February 2023 /PRNewswire/ — Syqe Medical, the developer of innovative technologies in the world of medical devices, is pleased to announce the signing of an agreement with the Israeli Ministry of Defense to supply the SyqeAir inhaler and cartridges to all veterans, who have prescribed medicinal cannabis by inhalation through the company’s pioneering platform. This first-of-its-kind agreement allows veterans treated with medical cannabis using the SyqeAir inhaler and cartridges to obtain them directly in the same way they access pharmaceutical drugs, placing SyqeAir’s precise, consistent and consistent treatment as the standard of care in medical cannabis.

SyqeAir Inhaler and Cannabis Cartridges for precise, consistent and safe medical cannabis treatment.

The SyqeAir inhaler is a revolutionary device that allows patients to effectively and precisely manage their medical cannabis treatment, ensuring optimal therapeutic benefit. It is composed of a unique, patented, metered dose system that precisely controls the amount of cannabis delivered to the patient with each inhalation. This allows for precise dosing and a high degree of patient control over their treatment. The SyqeAir inhaler is CE (European standard) and MDL (Health Canada) approved and clinically validated by 3 clinical trials and real-world evidence publications demonstrating its safety and effectiveness.

The inhaler is designed for easy home use as well as for a hospital environment. The pre-filled cartridge contains 60 uniform doses of standardized, raw pharmaceutical grade cannabis flowers grown by the Dutch company Bedrocan. From the moment the cartridge is inserted into the inhaler, the inhaler is ready for immediate use without prior preparation or the need to handle cannabis directly, so patients can take their treatment discreetly and as part of their daily routine like any other medicine.

Challenge usCEO of SyqeAir, said: “We are proud of the strategic partnership with the Department of Defense and the opportunity to bring our breakthrough technology, the SyqeAir inhaler, to veterans in need of medical cannabis treatment. It is our privilege to help veterans who suffer primarily from chronic pain and PTSD to establish a functioning everyday life for themselves, and we are honored by the opportunity to have a positive impact on their lives.

Jacob Vogeldirector of global sales and business development, added: “It’s been a long journey to get to this point, but it’s really rewarding to see the impact that the SyqeAir inhaler is having on our patients’ lives. The fact that we are able to provide veterans with a treatment option that has a real, positive impact on their daily functionality makes all the hard work worth it. We hope this partnership will serve as a model for other countries to follow in giving veterans the best possible medical treatment.”

About Syqe Medical

Syqe Medical is a pioneering MedTech company founded with the mission to relieve the suffering of as many patients as possible in the fastest possible way through advanced technologies. Syqe disrupted the pharmaceutical industry with their revolutionary technologies capable of delivering uniform doses of molecules by inhalation. The company’s flagship product, the SyqeAir inhaler, is the world’s only platform that enables doctors and patients to control medical cannabis treatment with measured, precise and consistent doses, ensuring optimal therapeutic benefit.


Telephone. +972-3-376-7338
E-mail. [email protected]

Syqe Medical Announces Agreement with Israeli Ministry of Defense to Provide SyqeAir Technology to Veterans, Business News

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top